<DOC>
	<DOCNO>NCT00906126</DOCNO>
	<brief_summary>A phase I , open-label trial determine safe dose oral misoprostol require augment labor nulliparous woman diagnose arrest dilation .</brief_summary>
	<brief_title>Oral Misoprostol Labor Augmentation : A Pilot Study</brief_title>
	<detailed_description />
	<mesh_term>Dilatation , Pathologic</mesh_term>
	<mesh_term>Misoprostol</mesh_term>
	<criteria>nulliparous gestational age least 36 week singleton gestation cephalic presentation reassure fetal heart rate 4 cm great cervical dilation rupture membrane clear amnionic fluid intrauterine pressure catheter place le 200 MVU 's nonreassuring fetal heart rate meconiumstained amnionic fluid previous uterine incision maternal fever pregnancyinduced hypertension pregnancyrelated complication know fetal anomaly placenta previa unexplained vaginal bleeding estimate fetal weight 4,500 gram great evidence cephalopelvic disproportion moderate severe preexist disease contraindication use prostaglandin</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>May 2009</verification_date>
	<keyword>oral misoprostol</keyword>
	<keyword>labor augmentation</keyword>
	<keyword>arrest dilation</keyword>
	<keyword>nulliparous</keyword>
</DOC>